Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter]

Abstract

Bhaskar Rege,1 Jonathan M Meyer2 1Pharmaceutical & Early Stage Clinical Development, Alkermes, Inc., Waltham, MA, USA; 2Department of Psychiatry, University of California, San Diego, CA, USACorrespondence: Bhaskar Rege, Alkermes, Inc., 852 Winter Street, Waltham, MA, 02451, USA, Email [email protected]

Keywords

• antipsychotic
• bipolar i disorder
• long-acting injectable
• schizophrenia